Filing Details

Accession Number:
0000711377-10-000037
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-12 15:37:18
Reporting Period:
2010-10-07
Filing Date:
2010-10-12
Accepted Time:
2010-10-12 15:37:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188987 A Terri Morrical Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-10-07 321 $13.55 10,595 No 4 M Direct
Common Stock Disposition 2010-10-07 321 $34.04 10,274 No 4 S Direct
Common Stock Acquisiton 2010-10-08 941 $13.55 11,215 No 4 M Direct
Common Stock Disposition 2010-10-08 941 $34.07 10,274 No 4 S Direct
Common Stock Acquisiton 2010-10-11 13,065 $13.55 23,339 No 4 M Direct
Common Stock Disposition 2010-10-11 13,065 $34.00 10,274 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option (Right to buy) Disposition 2010-10-07 321 $0.00 321 $13.55
Common Stock Common Stock Option (Right to buy) Disposition 2010-10-08 941 $0.00 941 $13.55
Common Stock Common Stock Option (Right to buy) Disposition 2010-10-11 13,065 $0.00 13,065 $13.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
38,201 2012-08-09 No 4 M Direct
37,260 2012-08-09 No 4 M Direct
24,195 2012-08-09 No 4 M Direct
Footnotes
  1. The options were granted 8/9/07 as Non-Qualified Options and became exercisable 20% yearly thereafer.